|
Forecast Period
|
2024-2028
|
|
Market Size (2022)
|
USD 2.43 Billion
|
|
CAGR (2023-2028)
|
5.77%
|
|
Fastest Growing Segment
|
Digital
|
|
Largest Market
|
North America
|
Market Overview
Global Mammography Devices Market has valued at USD 2.43 Billion in 2022
and is anticipated to project impressive growth in the forecast period with a
CAGR of 5.77% through 2028. Mammography devices are medical devices that use
low-dose X-rays to examine the breast architecture and diagnose breast cancer.
It's a minimally invasive screening technique that can detect breast cancer
before symptoms appear. Mammography Devices uses various approaches such as
computer-aided detection, digital mammography, and breast tomosynthesis. It is
commonly used to screen patients showing signs of breast cancer like lumps or
discomfort. During mammography, the patient's breast is placed on a support
plate and compressed with a paddle while a burst of X-rays passes through to a
detector. The resulting mammograms capture images of the breast tissue, with
low-density tissues appearing translucent and dense tissues or tumors appearing
white. Invasive breast cancer affects approximately one in eight women in the
United States, with around 266,120 women diagnosed in 2018. Additionally, about
2,550 men will be affected by invasive breast cancer in the same year (NCBI).
Key Market Drivers
Growing Burden of Breast Cancer
The growing burden of breast cancer is increasing the demand for
mammography devices, as early detection and accurate diagnosis are paramount in
the battle against this pervasive disease. Breast cancer is one of the most
common forms of cancer among women worldwide, and its incidence continues to
rise. In response to this alarming trend, mammography has emerged as an
essential tool for screening and diagnosing breast cancer at its earliest and
most treatable stages.
The demand for mammography devices has also been fueled by the
increasing awareness of the benefits of early detection and the continuous
advancements in imaging technology. Innovations like 3D mammography provide
clearer and more detailed images, reducing the likelihood of false positives
and false negatives. Additionally, the development of more comfortable and
patient-friendly Mammography Devices has encouraged more women to undergo
regular screenings, further contributing to the demand for these devices.
The growing burden of breast cancer has placed a heightened emphasis on
the need for effective and accessible screening methods. Mammography devices
have emerged as vital tools in the fight against breast cancer, and their
demand is expected to continue rising as healthcare systems globally strive to
improve early detection rates, reduce mortality, and enhance the overall
quality of care for breast cancer patients.
Technological Advancements in the Field of Breast Imaging
Technological advancements in the field of breast imaging are driving an
increased demand for mammography devices, revolutionizing the way breast cancer
is detected and diagnosed. These innovations are essential in improving the
accuracy, efficiency, and patient experience associated with breast screenings.
Digital mammography represents a significant leap forward from traditional
film-based systems. It provides clearer and more easily manipulated images,
reducing the need for retakes and enabling radiologists to detect abnormalities
with greater precision. Moreover, the integration of computer-aided detection
(CAD) software with digital mammography has enhanced the diagnostic
capabilities by helping identify subtle lesions that might be overlooked by
human eyes.
The introduction of 3D mammography, or tomosynthesis, has been a
game-changer in breast imaging. This technology creates three-dimensional
images, allowing radiologists to examine breast tissue layer by layer. This
significantly reduces the incidence of false positives and false negatives,
leading to more accurate diagnoses and fewer unnecessary follow-up tests.
Technological advancements have also led to improvements in patient
comfort during mammography procedures. Ergonomically designed mammography
devices and softer compression techniques have made the experience less painful
and intimidating for women, encouraging more frequent and timely screenings. Furthermore,
the integration of artificial intelligence (AI) into mammography is poised to
further transform breast imaging. AI algorithms can assist radiologists in
detecting subtle abnormalities, streamline workflow, and reduce interpretation
time, making the entire process more efficient.
Increasing Mature Markets
Most of the growth in the global mammography market can be attributed to
the mature markets of Western Europe, North America, South Korea, and Japan.
These markets have well-established breast cancer screening programs that are
adequately funded and reimbursed. Additionally, they boast a relatively high
level of awareness, participation, and coverage when it comes to breast cancer
screening.
One key factor contributing to the growth of these mature markets is the
presence of a large installed base of equipment. As a result, purchases in
these markets are often cyclical, aimed at replacing outdated equipment.
However, it is worth noting that the year 2018 witnessed a unique trend in
these markets. The demand for replacement equipment reached its peak due to a
combination of factors.
During this period, there was an increase in breast cancer incidence and
mortality rates, which coincided with improved awareness, coverage, and
participation in breast cancer screening programs. This led to a surge in
demand for new Mammography Devices. Moreover, stronger economies in these
regions resulted in increased funding for healthcare providers. As a result,
they were able to replace outdated systems with more advanced Mammography
Devices, thereby driving uncharacteristically high growth in the mature
mammography markets.
Investment from Various Organizations in Breast Cancer Screening
Campaigns
Government sponsorship of mammography, primarily through the
implementation of breast cancer screening programs, plays a significant role in
shaping a nation's mammography market in terms of size and development.
However, it is important to note that not all screening programs have equal
impact on the market. Generally, nations with well-established screening
programs tend to have larger and more mature mammography markets, whereas the
absence of such programs results in smaller emerging markets. The unique needs
and demands of their respective breast cancer screening programs contribute to
the growth of mature and emerging mammography markets, thus influencing global
mammography revenue. The increasing investment from various organizations in
breast cancer screening campaigns is playing a pivotal role in driving up the
demand for mammography devices. Breast cancer remains a significant global
health concern, and organizations, both public and private, recognize the
importance of early detection as a cornerstone in the fight against this
disease.
Investments in breast cancer screening campaigns are primarily aimed at
raising awareness and encouraging women to undergo regular mammography
screenings. These campaigns often include educational initiatives, outreach
programs, and advocacy efforts to emphasize the importance of early detection
and the benefits of mammography in improving survival rates. As a result, more
women are becoming aware of the necessity of regular breast screenings, which
directly contributes to the increased demand for mammography devices. Furthermore,
research organizations and charities invest in cutting-edge technologies and
research to enhance the sensitivity and accuracy of mammography devices. This
encourages the development and adoption of advanced Mammography Devices, such
as digital mammography and 3D tomosynthesis, which further stimulates demand as
healthcare providers seek to offer the latest and most effective breast imaging
solutions to their patients.
Investment from various organizations in breast cancer screening
campaigns is instrumental in raising awareness, improving accessibility, and
advancing technology in the field of breast imaging. This collective effort
significantly increases the demand for mammography devices, as more healthcare
facilities strive to provide state-of-the-art breast cancer screening services
to their communities, ultimately leading to earlier detection and improved
outcomes for breast cancer patients.
Download Free Sample Report
Key Market Challenges
Reduction in Reimbursement
The reduction in reimbursement rates for mammography services is having
a negative impact on the demand for mammography devices. Mammography is a
critical tool in the early detection of breast cancer, and its accessibility is
crucial for ensuring that women receive timely and effective screening. When
reimbursement rates decrease, it creates several challenges that can deter
healthcare providers from investing in or maintaining mammography devices. Reduced
reimbursement rates directly affect the financial viability of offering
mammography services. Healthcare facilities often rely on reimbursements from
government programs and private insurers to cover the costs associated with Mammography
Devices, staffing, maintenance, and overhead. When reimbursement rates are
lowered, it can lead to financial losses for providers, making it less
economically feasible to maintain or invest in modern mammography technology.
Lower reimbursement rates may lead to a reduction in the number of
facilities offering mammography services. Smaller healthcare providers and
clinics, in particular, may find it increasingly difficult to sustain
mammography programs under reduced reimbursements, potentially limiting access
to screenings for women in underserved or rural areas. Moreover, decreased
reimbursement rates may discourage healthcare providers from investing in
advanced mammography technology, such as 3D tomosynthesis or digital mammography,
which can improve the accuracy of breast cancer detection. Providers may opt
for older, less costly equipment that may not offer the same level of
diagnostic capability.
Risk of Adverse Effects from Radiation Exposure
The risk of adverse effects from radiation exposure is a significant
factor contributing to concerns and, in some cases, a decrease in the demand
for mammography devices. While mammography is an invaluable tool for breast
cancer screening and early detection, the exposure to ionizing radiation during
the procedure has raised apprehensions among patients and healthcare providers.
One primary concern is the cumulative radiation dose over a woman's
lifetime, especially for those who undergo routine mammograms. Prolonged
exposure to ionizing radiation carries a potential risk of causing DNA damage
and an increased likelihood of cancer development, albeit at relatively low
levels. This heightened awareness of radiation risks has prompted some
individuals to question the frequency of mammography screenings, potentially
reducing demand for the service.
Additionally, women who may be particularly sensitive to radiation or
have a higher genetic predisposition to radiation-induced cancers may express
reluctance to undergo mammography. This can deter healthcare providers from
recommending mammograms and, subsequently, impact the demand for mammography
devices. While the risk of adverse effects from radiation exposure is a valid
concern associated with mammography, advances in technology have helped
mitigate these worries to some extent. The adoption of lower-dose mammography
options is crucial in maintaining confidence in the safety of breast cancer
screenings, thereby ensuring that the demand for mammography devices remains
steady and that women continue to receive the benefits of early breast cancer
detection.
Key Market Trends
AI and Computer-Aided Detection (CAD)
Artificial intelligence and machine learning algorithms are being
integrated into mammography devices to aid radiologists in identifying
abnormalities and improving the accuracy of interpretations. AI-powered CAD
systems will likely become more advanced, helping to streamline the reading
process and reducing interpretation errors. AI algorithms are trained on large
datasets of mammograms to learn patterns associated with normal and abnormal
breast tissue. These algorithms can detect subtle changes, microcalcifications,
masses, or architectural distortions that might be indicative of cancer. They
analyze the mammography images pixel by pixel, identifying areas that warrant
closer inspection.
AI-driven CAD systems can significantly reduce false positives and false
negatives. False positives can cause unnecessary anxiety and follow-up
procedures, while false negatives can lead to missed cancer diagnoses. AI can
help radiologists pinpoint potential abnormalities more accurately, reducing
these errors. AI-powered CAD systems can help radiologists streamline their
workflow. They can highlight areas of concern on the mammogram, making it
quicker for radiologists to review the images and focus their attention on
regions that may require further evaluation. This efficiency can lead to faster
interpretation of mammograms. AI and machine learning are transforming
mammography by improving the accuracy of interpretation, reducing errors, and
enhancing radiologists' workflow. As these technologies continue to advance,
they are likely to become an integral part of breast cancer screening,
ultimately leading to earlier detection and improved outcomes for patients.
Portable and Point-of-Care Mammography
Smaller, portable mammography devices and point-of-care systems will
become more prevalent, enabling screenings in non-traditional settings like
mobile clinics and remote healthcare facilities. These devices will be
especially valuable in increasing access to mammography in resource-constrained
areas. Portable mammography devices are designed to be compact and lightweight,
making them easy to transport. This mobility allows healthcare providers to
take mammography services to remote or underserved regions where access to
traditional healthcare facilities may be limited.
These devices are ideal for use in mobile healthcare clinics or vans,
which can travel to rural or remote communities. Mobile clinics equipped with
portable mammography units can provide on-site breast cancer screenings,
eliminating the need for patients to travel long distances for a mammogram. Portable
mammography devices are well-suited for use in smaller, remote healthcare
facilities that may lack the space or infrastructure for larger, fixed
mammography machines. These devices can be set up in primary care clinics,
community health centers, or even temporary medical camps.
Portable mammography systems typically require less infrastructure and
shielding compared to their larger, fixed counterparts. This can significantly
reduce the cost of setting up and maintaining a mammography facility, making it
more feasible for resource-constrained areas to offer breast cancer screening
services. The ability to conduct mammography screenings in non-traditional
settings means that women in underserved areas are more likely to receive
timely breast cancer screenings. Early detection is crucial for improving
outcomes, and portable devices help bridge the gap in access to healthcare. Portable
mammography devices can also be invaluable during disaster response efforts. In
the aftermath of natural disasters or humanitarian crises, they can be quickly
deployed to ensure that breast cancer screenings continue for affected
populations.
Segmental Insights
Technology Insights
Based on technology,
the market is segmented into digital and analog. The digital mammography
segment is projected to capture a larger market share in the forecast period.
Digital mammography, an advanced and specialized form of mammography, utilizes
digital computers and receptors instead of X-ray films to examine breast tissue
for cancer indicators. Technological advancements have spurred the emergence of
digital mammography, offering advantages such as superior depiction of
low-contrast objects, improved diagnostic image quality, and wider dynamic
range. With a growing number of healthcare facilities adopting these modern
systems, they also facilitate easy sharing of soft-copy image displays and
soft-copy reading across devices. These factors have made digital mammography a
favored choice among healthcare providers, while also ensuring significantly
lower radiation exposure compared to conventional systems.
End User Insights
Based on the end user
segment, hospitals and clinics dominated the end user segment in 2022,
accounting for approximately 45.6% of the total revenue. The presence of
mammography facilities within hospitals can have a positive impact on various
factors, including hospital stay duration, healthcare cost, care quality, and
emergency care availability. For example, in September 2019, Parkside Hospital
in Wimbledon installed a 3Dimensions mammography system from Hologic, enabling
high-resolution breast tomosynthesis.
Large hospitals
typically have in-house mammography facilities, but the need for substantial
investments, frequent maintenance, adequate space, and skilled professionals
can pose entry barriers. This can burden hospitals in managing their medical
imaging facilities. To alleviate this burden and expand the reach of their
services, hospitals can establish partnerships with diagnostic centers to
provide medical imaging facilities.
The diagnostic
centers segment is expected to experience significant growth during the
forecast period, driven by increased awareness about breast cancer. This has
led to a surge in demand for mammography procedures for diagnosis, treatment
planning, and prevention of breast cancer. The availability of advanced
mammography services in diagnostic centers in developed and developing
economies, such as the United States, Germany, the United Kingdom, Japan,
China, and India, is anticipated to drive the overall segment's growth.
Download Free Sample Report
Regional Insights
North America currently dominates the Mammography Devices market and are
expected to maintain this position in the foreseeable future. Leading firms
consistently strive to develop technologically advanced solutions and address
the increasing incidence of breast cancer in the region. Governments are making
significant investments in establishing camps and free check-up facilities to
detect breast cancer, aiming to mitigate the severity of the situation. In the
United States, market participants are expanding their consumer bases through
numerous collaborations and acquisitions, contributing to the industry's
expansion.
The Asia Pacific region is witnessing a rapid growth in the market for Mammography
Devices. This can be attributed to the surging incidence of breast cancer, the
expansion of healthcare systems, the availability of a large number of
oncologists, and the rapid economic growth of countries such as Japan and
India. Governments in the region are taking initiatives to raise awareness
about cancer and its impact on life by organizing various camps. For instance,
the Japan Society of Breast Health, J. POSH, and the Japan Cancer Society
(Smile Fund) receive donations from Wacoal Corp., which also sponsors the Pink
Ribbon Fitting Campaign.
Recent Developments
- Volpara Health
introduced updated products for its integrated platform for personalized breast
care at the SBI/ACR Breast Imaging Symposium 2022 in May 2022. Volpara's
AI-driven breast software tools offer mammography quality and reporting,
volumetric breast density measurements, and cancer risk assessment.
- ScreenPoint Medical
expanded its presence in the United States and 30 other countries worldwide
with the launch of Transpara, an AI Breast Care system, in January 2022.
- In June 2021, iCAD
Inc received CE Mark approval for ProFound AI® Version 3.0 for Digital Breast
Tomosynthesis (DBT) software. This latest version demonstrates up to a 10%
improvement in specificity performance while maintaining an industry-leading
high sensitivity level.
- Hologic Inc obtained
product approval from the US Food and Drug Administration for their Genius AI
Detection technology, a new deep learning-based software, in December 2020.
This software, when used alongside the Genius 3D Mammography exam, aids in the early
detection and identification of breast cancer.
- Therapixel received
US FDA approval for MammoScreen, a computer-assisted detection and diagnosis
software, in March 2020. This software assists clinicians in identifying
relevant findings when used with compatible full-field digital mammography
systems.
Key Market Players
- Hologic, Inc.
- Fujifilm Holdings Corporation
- Philips Healthcare
- Siemens Healthineers AG
- GE Healthcare
- Carestream Health, Inc.
- Konica Minolta Inc.
- Delphinus Medical Technologies, Inc.
- Analogic Corporation
- KUB Technologies, Inc.
|
By Product Type
|
By Technology
|
By End User
|
By Region
|
|
- Full-field Digital Mammography
- Film-screen Mammogram
- Breast Tomosynthesis
|
|
- Hospitals & Clinics
- Diagnostic Centres
- Others
|
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
|
|
|
|
|
|
|
|
|
Report Scope:
In this report, the Global Mammography Devices Market has been segmented
into the following categories, in addition to the industry trends which have
also been detailed below:
- Mammography Devices Market, By Product Type:
o
Full-field Digital Mammography
o
Film-screen Mammogram
o
Breast Tomosynthesis
- Mammography Devices Market, By Technology:
o
Digital
o
Analog
- Mammography Devices Market, By End User:
o
Hospitals & Clinics
o
Diagnostic Centres
o
Others
- Mammography Devices Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
§ Turkey
§ Egypt
Competitive Landscape
Company Profiles: Detailed
analysis of the major companies present in the Global Mammography Devices Market.
Available Customizations:
Global Mammography Devices market report with the given market
data, Tech Sci Research offers customizations according to a company's specific
needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
Global Mammography Devices Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]